Inc. Archives

Glycomimetic peptides as powerful anti-inflammatory treatments

Written by

Glycan (sugar)-binding lectin-type receptors on immune cells have the potential to serve as therapeutic targets. However, many of these receptors are not targeted because of a lack of suitable binding agents. Professor J Kenneth Hoober and Dr Laura L Eggink, co-founders of Susavion Biosciences, Inc, and Wild Boar Biosciences, LLC, have created peptide mimetics of glycans that show greater flexibility […]

Diverse Horizons: Investing globally in social and environmental sustainability

Written by

Tony Marshall has founded both Diverse Horizons, Inc. and The Diverse Horizon Foundations to provide multiuse community-based facilities to provide educational opportunities around environmental sustainability and social equality.

The issues of climate change, environmental degradation, and social inequality are growing ever more challenging. Considering these problems, global goals for sustainable development have encouraged treaties such as the Paris Agreement and the proposed Green New Deal. Mr Tony Marshall, the Founder, President, and CEO of his corporations Diverse Horizons, Inc. and The Diverse Horizons Foundation, has been diligent in […]

Electron paramagnetic resonance: EPR everywhere

Written by

Electron paramagnetic resonance (EPR) measures the signal from unpaired electrons and is a technique already widely used in the bioscience and pharmaceutical industries. Dr Joshua R. Biller of TDA Research, Inc, USA is championing the novel use of EPR to answer research questions. He explains that rapid innovations in EPR will allow a wider group of researchers to image tumours, […]

Centhaquine: A new resuscitative agent for haemorrhagic shock

Written by

Triggered by severe blood loss, haemorrhagic shock is a type of hypovolemic shock, an often-fatal condition. Treatments are available but haven’t been updated for a long time – there is a need for a new resuscitative agent to help patients survive and recover. Luckily, Dr Anil Gulati, of Pharmazz, Inc., has developed centhaquine, aka Lyfaquin®. This drug has shown very […]

New synthetic biology method revolutionises DNA cloning

Written by

Since the dawn of humanity, we have been modifying and altering the natural environment to suit our needs, from domestication of animals and plants to the modification of landscapes. Using synthetic biology, Dr Jeff Braman and Dr Peter Sheffield at Agilent Technologies, Inc. have developed a new method to assemble DNA. Their approach allows seamless assembly of independent, functionally tested, […]

Polymeric transformer: Nanoantibiotics for drug-resistant infections

Written by

The translational research of Professor Young Jik Kwon at the University of California, Irvine aims to fill a formidable void created by the lack of available effective antibiotics. Combining naturally-occurring antimicrobial substances with conventional antibiotics, Professor Kwon’s nanoantibiotics are a novel generation of compounds molecularly engineered to safely and effectively target drug-resistant bacteria. One of his current projects aims to tackle […]